Rafael H. Llinas, M.D.
Rafael H. Llinas, M.D., F.A.H.A., is the chairman and neurologist-in-chief of the department of neurology at Johns Hopkins Bayview Medical Center. He also serves as director of the Johns Hopkins neurology residency and is a member of the Johns Hopkins acute stroke team.
Dr. Llinas received his bachelor of arts degree from Washington University in St. Louis and his doctor of medicine degree from the New York University School of Medicine. He completed his residency in neurology at the Harvard Longwood Program based at Brigham and Women’s Hospital. He also completed a two-year fellowship in cerebrovascular medicine at Beth Israel Hospital in Boston.
Dr. Llinas is a member of the American Heart Association’s stroke division and the Maryland stroke task force. His research interests include neurosonology, diffusion/perfusion imaging, the use of neuroprotective agents, and secondary stroke prevention. He has published articles in Stroke, Neurology, New England Journal of Medicine, AJNR, Journal of Cerebrovascular Disease, and Annals of Neurology.
Latest by Rafael H. Llinas, M.D.
Stroke rehabilitation begins almost immediately after being admitted to the hospital and often continues for at least one to two months afterward. The primary goal is to prevent stroke complications, such as stiffening of the limbs and deep vein thro...
The potential for recovery depends on which portions of the brain were damaged by the stroke. Here’s what you need to know.
Like a heart attack, a stroke or transient ischemic attack (TIA) is an emergency that requires immediate medical attention. Here are the signs to watch for and what you should do.
In older men, two sleep abnormalities may increase the risk of atrial fibrillation and stroke.
Patients with atrial fibrillation who are candidates for anticoagulants and don’t use them take the risk of having a stroke. Here’s what to consider.
This ministroke is a warning sign that a full-blown ischemic stroke may be in your future.
If you’re one of the roughly 2.7 million Americans who has atrial fibrillation, the most common form of abnormal heart rhythm, you could benefit from new, game-changing drugs and strategies.
New guidelines about what to eat, and more.